Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

• Egile Nagusiak: Claire M. Zagorski (Egilea), Rebecca A. Hosey (Egilea), Christopher Moraff (Egilea), Aaron Ferguson (Egilea), Mary Figgatt (Egilea), Shoshana Aronowitz (Egilea), Natalie E. Stahl (Egilea), Lucas G. Hill (Egilea), Zoe McElligott (Egilea), Nabarun Dasgupta (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2023-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Objectives Xylazine has emerged as a consistent part of the unregulated drug supply in recent months. We discuss major domains of xylazine's harm, current knowledge deficits, clinical and harm reduction strategies for minimizing harm, and xylazine's public health and policy contex...